Beyond Nicotine Gateway Hypothesis

Somchai Bovornkitti
Additional contact information
Somchai Bovornkitti: The Academy of Science, The Royal Society of Thailand, Bangkok

JOJ Internal Medicine, 2019, vol. 1, issue 2, 62-63

Abstract: “A gateway drug is a drug that lowers the threshold for addiction to other agents†[1]. Psychological studies involving humans suggested that addiction is a form of learning and that relapse is a persistent memory of the drug experiences [2]. It is the gene transcription factor cyclic AMP response-element-binding protein (CREB) acting as a switch, converting short-term memory to long-term memory, referred to as the acetylation of chromatin structures [3]. For nicotine gateway hypothesis, data from a group of students, aged 15.7 to 34.2 years, showing the majority of cocaine users (75.2%) were smoking during the month they began using cocaine [4], and the rate of cocaine dependence was highest (20.2%) among users who started using cocaine after having smoked cigarettes, in contrast to dependence among persons who had begun using cocaine before they started smoking (6.3%) and among those who had never smoked more than 100 cigarettes (10.1%) [5].

Keywords: journal of orthopaedics; orthopaedics journals impact factor; orthopaedics articles impact factor; scholarly publishing orthopedics journals; juniper publishers opena ccess orthopedics journal; Rheumatology; rheumatology journals impact factor 2018; rheumatology journals impact factor; rheumatology open access journals; juniper publishers review (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jojim/pdf/JOJIM.MS.ID.555563.pdf (application/pdf)
https://juniperpublishers.com/jojim/JOJIM.MS.ID.555563.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jjojim:v:1:y:2019:i:2:p:62-63

DOI: 10.19080/JOJIM.2019.01.555563

Access Statistics for this article

JOJ Internal Medicine is currently edited by Sophia Mathis

More articles in JOJ Internal Medicine from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().